Compound Summary
Sodium valproate
Compound Information
Sodium valproate
Compound Name: | Sodium valproate |
Compound CID: | 16760703 |
Synonyms: | Sodium valproate Sodium 2-propylpentanoate 1069-66-5 Valproate sodium Valproic acid sodium salt More... |
Iupac Name: | sodium;2-propylpentanoate |
InChI: | InChI=1S/C8H16O2.Na/c1-3-5-7(6-4-2)8(9)10;/h7H,3-6H2,1-2H3,(H,9,10);/q;+1/p-1 |
InChIKey: | AEQFSUDEHCCHBT-UHFFFAOYSA-M |
Canonical Smiles: | CCCC(CCC)C(=O)[O-].[Na+] |
Isomeric Smiles: | CCCC(CCC)C(=O)[O-].[Na+] |
Molecular Weight: | 166.19 |
Molecular Formula: | C8H15NaO2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Sodium valproate
Molecular Weight: | 166.19 |
Molecular Formula: | C8H15NaO2 |
Hydrogen Bond Donor Count: | 0 |
Hydrogen Bond Acceptor Count: | 2 |
Rotatable Bond Count: | 5 |
Heavy Atom Count: | 11 |
Complexity: | 98.3 |
Synonyms
Sodium valproate
| Sodium valproate | Sodium valproate |
|---|---|
Sodium valproate |
Sodium 2-propylpentanoate |
1069-66-5 |
Valproate sodium |
Valproic acid sodium salt |
Valproic acid sodium |
Epilim |
Valproic Acid (sodium salt) |
Pentanoic acid, 2-propyl-, sodium salt |
Sodium 2-propylvalerate |
2-Propylvaleric acid sodium salt |
Valerin |
2-Propylpentanoic acid sodium salt |
UNII-5VOM6GYJ0D |
Valproic acid sodium salt (1:1) |
Valproic Acid, Sodium Salt |
2-propylpentanoic acid sodium |
Valproate |
Valproic acid sodium salt (Sodium valproate) |
sodium;2-propylpentanoate |
MFCD00078604 |
5VOM6GYJ0D |
Abbott 44090 |
CHEBI:9925 |
Eurekene |
Labazene |
Orfiril |
DEPACON |
Depakene (TN) |
Natrium valproat |
Dipropylacetate sodium |
Sodium dipropylacetate |
Sodium valproate (2-Propylpentanoic acid, sodium salt) |
Sodium bispropylacetate |
CHEMBL433 |
Valproinsaeure, natrium |
Sodium n-dipropylacetate |
SMR000875243 |
Sodium 2-n-propyl-pentanoate |
KW 6066N |
EINECS 213-961-8 |
Valeric acid, 2-propyl-, sodium salt |
2-Propylpentanoic Acid, Na |
Valproate sodium USAN:USP |
A-44090 |
Selenica (TN) |
Lopac-P-4543 |
Valproate sodium (USAN) |
Sodium valproate (JP17) |
DSSTox_CID_17072 |
DSSTox_RID_79301 |
DSSTox_GSID_37072 |
SCHEMBL35027 |
MLS001332431 |
MLS001332432 |
MLS002153189 |
SPECTRUM1500606 |
ABBOTT-44090 |
DTXSID5037072 |
HMS500N15 |
Valproic acid sodium salt, 98% |
HMS1921I21 |
HMS2092C12 |
HMS2230E16 |
HMS3262B20 |
HMS3369L11 |
HMS3648A12 |
HMS3654I14 |
HMS3872G13 |
HMS3884E05 |
BCP02888 |
KW-6066N |
Tox21_302623 |
Tox21_500889 |
CCG-40071 |
HY-10585A |
s1168 |
AKOS005066057 |
AC-8391 |
CCG-208088 |
CCG-266330 |
CS-1764 |
LP00889 |
NSC 732626 |
NSC 757376 |
NCGC00016192-01 |
NCGC00016192-02 |
NCGC00016192-03 |
NCGC00016192-04 |
NCGC00094208-01 |
NCGC00094208-02 |
NCGC00094208-03 |
NCGC00167849-01 |
NCGC00256651-01 |
NCGC00261574-01 |
AS-13150 |
H456 |
SY058189 |
BCP0726000316 |
CAS-1069-66-5 |
AB0013058 |
DB-059527 |
EU-0100889 |
FT-0633278 |
S0894 |
SW219169-2 |
D00710 |
H11308 |
P 4543 |
Pentanoic acid, 2-propyl-, sodium salt (1:1) |
Valproic Acid, Sodium Salt - CAS 1069-66-5 |
Q-201918 |
Q4347890 |
Sodium valproate, British Pharmacopoeia (BP) Reference Standard |
Sodium valproate, European Pharmacopoeia (EP) Reference Standard |
Experimental Data
Sodium valproate
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -2.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
Sodium valproate
Statistics Data
Sodium valproate
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -2.000000000000000 | 1 | 1 |
Statistics Data Visualization
Sodium valproate
